A cancer diagnosis changes how you think about a lot of things — and life insurance is often near the top of that list. The good news is that more cancer survivors qualify for traditional life insurance than most people realize.
The carrier you apply with, the time since treatment, and the specifics of your diagnosis all matter. Here’s what to expect.
How underwriters approach cancer history
Insurance underwriters review cancer cases constantly. They have detailed guidelines for virtually every type, stage, and treatment combination — and the questions they ask are predictable.
What was the type of cancer? What was the stage at diagnosis? What treatments were performed? When did treatment end? What does your follow-up care look like, and is there any evidence of recurrence?
The framework underwriters use is consistent across carriers: lower stage, complete treatment, longer disease-free period, and consistent follow-up care add up to better rates. Where carriers differ is in how strictly they apply that framework — and that’s where carrier selection makes a meaningful difference.
A broker who regularly places cancer cases knows which companies take the most favorable view of breast cancer, which are most lenient on prostate cancer, and which specialize in higher-risk histories. Applying with the wrong carrier is one of the most common reasons cancer survivors end up with worse rates than they should have received.
Breast cancer
Breast cancer is one of the most common cancer histories underwriters review, and the underwriting picture is generally favorable for early-stage cases.
Stage 0 (DCIS): Often treated similarly to a precancerous condition. Standard or even preferred rates are achievable at most carriers after a one-to-two year disease-free period.
Stage I and II: Insurable at standard rates at many carriers after a disease-free period of two to five years post-treatment, depending on tumor characteristics, hormone receptor status, and treatment specifics.
Stage III: Coverage is available but the carrier pool narrows. Most carriers want five or more years disease-free, and a table rating is common.
Stage IV: Traditional coverage is generally not available through standard carriers. Guaranteed issue whole life is the realistic option for ongoing protection.
What helps: clean follow-up mammograms, hormone therapy compliance if prescribed, and consistent oncology check-ins.
Prostate cancer
Prostate cancer is one of the more favorable cancer histories from an underwriting standpoint, particularly for early-stage diagnoses, because it’s often slow-growing and highly treatable.
Low-grade, localized prostate cancer (Gleason 6 or below): Many carriers offer standard rates after as little as one to two years disease-free. Some will go to preferred rates with strong supporting factors.
Intermediate-grade (Gleason 7): Standard rates are typically achievable after two to five years disease-free.
High-grade (Gleason 8 or above): Coverage is available but more restricted. Carriers want a longer disease-free period — typically five years — and a table rating is common.
PSA monitoring documentation is critical. Underwriters want to see consistent post-treatment PSA readings showing stability.
Colon and colorectal cancer
Colorectal cancer outcomes vary significantly by stage at diagnosis, and underwriting reflects that.
Stage 0 and Stage I: Insurable at standard rates at most carriers after a two-to-three year disease-free period. Some carriers will offer preferred rates for very early-stage cases with clean follow-up.
Stage II and III: Standard rates achievable after three to five years disease-free, often with mild table ratings depending on specifics like lymph node involvement and treatment response.
Stage IV: Traditional coverage is generally not available. Guaranteed issue is the realistic option.
What helps: documented surveillance colonoscopies showing no recurrence and clean post-treatment imaging.
Lung cancer
Lung cancer is one of the more challenging histories for underwriters because survival rates have historically been lower than other major cancers — though early-detection cases now have much more favorable long-term outcomes.
Stage I non-small cell lung cancer caught early: Coverage is available at select carriers after a five-year disease-free period. Standard rates are difficult; table ratings are common.
Stage II and III: Most carriers want a longer disease-free period — often seven or more years — and a table rating is the typical outcome when coverage is offered.
Stage IV or small cell lung cancer: Traditional coverage is generally not available. Guaranteed issue is the realistic option.
Smoking history is a major factor in any lung cancer case. Carriers will look at when you quit, how long you smoked, and what your current pulmonary function looks like.
Other common cancers
Bladder cancer: Early-stage cases are generally insurable at standard rates after a two-to-three year disease-free period. Recurrence rates are watched closely.
Lymphoma and leukemia: These are highly variable depending on type. Hodgkin lymphoma cases that are fully treated and disease-free for five years are often insurable at standard rates. Non-Hodgkin and various leukemias require more case-by-case review.
Thyroid cancer: One of the most favorable cancer histories. Most cases are highly treatable and underwritten leniently — standard or preferred rates are often achievable after a one-to-two year disease-free period.
Cervical cancer: Early-stage cases are typically insurable at standard rates after two to three years disease-free.
Kidney cancer: Stage I cases are insurable at standard rates after a two-to-three year disease-free period at most carriers.
How long after treatment can you apply?
The minimum disease-free period varies by cancer type and stage, but a few patterns hold across the board.
For Stage 0 and Stage I cases of most common cancers, applying one to two years after treatment ends is typically when traditional coverage becomes available. For Stage II and III cases, the minimum waiting period is usually three to five years. Stage IV cases generally fall outside the traditional market.
Applying earlier than the minimum waiting period almost always results in a postponement rather than an approval. Use that waiting period productively — focus on follow-up care, document everything, and connect with an independent broker so you’re ready to move the moment you’re eligible.
What rates actually look like
Cancer underwriting produces some of the widest carrier-to-carrier rate differences in the entire life insurance market.
A 55-year-old non-smoker with Stage I breast cancer five years post-treatment might qualify for standard rates at one carrier and a Table 4 rating at another for the exact same coverage. The difference in monthly premium for $500,000 in 20-year term coverage could easily be $100 or more — that’s $1,200 per year on identical coverage.
This is why broker matters more in cancer cases than in almost any other underwriting situation. The right carrier can mean the difference between affordable coverage and a premium that’s not worth paying.
What helps your application
Have your treatment summary ready. Your oncologist can provide one. It documents your diagnosis, treatment, and outcome in the format underwriters expect.
Stay current with surveillance. Whether it’s mammograms, PSAs, colonoscopies, or imaging, consistent follow-up care is one of the strongest signals to underwriters that recurrence is being actively monitored.
Be completely transparent. Cancer history will appear in your medical records without exception. Disclosing it accurately and proactively is always better than having it surface during underwriting without context.
Work with a broker who specializes in cancer cases. This cannot be overstated. Cancer underwriting is one of the most carrier-specific areas of the life insurance market. The wrong carrier means paying more — or being declined when you should have been approved.
A note on skin cancer
Skin cancer is by far the most commonly diagnosed cancer in the United States and is treated very differently from the cancers covered above. If you’ve had basal cell, squamous cell, or melanoma, our dedicated guide covers the specifics in detail.
Get your free quote today
At Term Insurance Brokers, cancer cases are part of what we do every week. We represent more than 30 top-rated carriers and know exactly which companies take the most favorable view of each cancer type, stage, and treatment history.
There’s no cost to get a quote, and we do all the carrier shopping on your behalf. You tell us your history — we find the right home for your application.
Call us at 703-665-9133 or visit terminsurancebrokers.com for your free, no-obligation quote today.
Term Insurance Brokers is an independent brokerage licensed in 35+ states. We are not affiliated with any single insurance company.